http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107028965-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-33 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 |
| filingDate | 2017-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107028965-B |
| titleOfInvention | Application of yuenkanin or derivatives thereof in preparation of lipid-lowering drugs and product |
| abstract | The invention relates to the technical field of medicines, in particular to application of yuenkanin or derivatives thereof in preparation of lipid-lowering medicines and products. The study of the invention finds that the genkwanin can up-regulate the expression of the genes related to the promotion of cholesterol absorption and down-regulate the expression of the genes related to the promotion of fat synthesis, and shows that the genkwanin has obvious lipid-lowering effect and no toxicity to cells. |
| priorityDate | 2017-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 147.